Research roundup

Debbie Rigby covers the latest research relevant to pharmacists Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder This study represents the first evaluation of the relative benefits of onabotulinumtoxinA compared with mirabegron in adults with idiopathic overactive bladder. An indirect comparison indicates that onabotulinumtoxinA may be superior to mirabegron in improving symptoms of urinary